巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02367 巨子生物

已收盘 08-13 16:08:14

29.600

+0.480

+1.65%

最高29.640	最低28.740	成交量292.79万
今开29.120	昨收29.120	日振幅3.09%
总市值314.35亿	流通市值314.35亿	总股本10.62亿
成交额8,590万	换手率0.28%	流通股本10.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":29.6,"timestamp":1786608494002,"preClose":29.12,"halted":0,"volume":2927886,"delay":0,"changeRate":0.016483516483516498,"floatShares":1061999999,"shares":1061999999,"eps":2.1056388925315046,"marketStatus":"已收盘","change":0.48,"latestTime":"08-13 16:08:14","open":29.12,"high":29.64,"low":28.74,"amount":85898360,"amplitude":0.030907,"askPrice":29.6,"askSize":800,"bidPrice":29.56,"bidSize":600,"shortable":3,"etf":0,"ttmEps":2.1056388925315046,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":29.12,"dividendRate":0.046926,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":0.872433,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367","defaultTab":"news","newsList":[{"id":"1145049652","title":"财报前瞻｜巨子生物医美矩阵扩张带动业务修复，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1145049652","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145049652?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:24","pubTimestamp":1786407863,"startTime":"0","endTime":"0","summary":"巨子生物将于2026年08月18日盘后发布中期业绩，市场情绪围绕医美新品放量与渠道修复展开预期博弈。目前市场公开渠道未形成可引用的一致量化预测，公司管理层亦未披露当季明确指引，因此本季度营收、毛利率、净利润或净利率、调整后每股收益等具体预测值及同比数据暂无可得信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜巨子生物医美矩阵扩张带动业务修复，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658989817","title":"化妆品板块活跃 上美股份（02145）涨7.94%、毛戈平（01318）涨4.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989817","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658989817?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:00","pubTimestamp":1786348800,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股化妆品板块表现活跃，截至发稿，上美股份 涨7.94%，毛戈平涨4.25%，巨子生物涨3.38%。抖音化妆品GMV达1503.4亿元，同比增长14.5%，其中护肤品类增速放缓至9.9%，彩妆香水品类增长较快，同比增长39.2%；国货品牌仍保持64.1%的份额优势，但外资品牌已逐步适应内容电商逻辑，份额同比提升2个百分点至37.9%，渗透持续加速。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987847","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1224","BK1577","BK1502","BK1601","LU0348767384.USD","02145","BK1525","LU0455707207.USD","LU0502904849.HKD","LU2242644610.SGD","BK1602","SG9999004311.SGD","01318","LU0348766576.USD","00178","02367","LU2488822045.USD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151808711","title":"巨子生物（02367）拟于2026年8月18日审议中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1151808711","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151808711?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:44","pubTimestamp":1785919484,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司（02367）8月5日公告称，公司董事会已排期于2026年8月18日（星期二）召开会议，主要议程包括审议集团截至2026年6月30日止六个月的中期业绩、讨论及通过中期股息（如有）以及处理其他相关事项。\n本次会议由董事会主席严建亚主持。公告同时列明，截至公告日期，董事会由5名执行董事及3名独立非执行董事组成，成员包括：\n执行董事——严建亚、叶娟、方娟、张慧娟、严钰博；\n独立非执行董事——黄进、单文华、黄斯颖。\n公司表示，将在董事会会议后按相关规定公布中期业绩及派息决定（如有）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198481107","title":"巨子生物更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1198481107","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198481107?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:42","pubTimestamp":1785832934,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于2026年8月4日发布截至2026年7月31日的股份变动月报表。报告显示，法定注册股本仍为5,000,000,000股，面值0.00001美元，对应注册股本总额50,000美元，与上月保持一致。在股权激励方面，2023年8月17日采纳的2023年购股权计划显示，上月底结存的股份期权共10,930,400份，本月内变动10,930,400份，本月底结存期权数量为0份。公司表示，该月所有股份发行及其变动事宜均已履行相关上市规则、法律及监管规定。截至本月末，公司股本未发生实质变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656585766","title":"【券商聚焦】国泰海通：美护板块持仓估值处于底部 有望展现修复弹性","url":"https://stock-news.laohu8.com/highlight/detail?id=2656585766","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656585766?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:16","pubTimestamp":1785806188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国泰海通证券表示，美护板块持仓估值处于底部，有望展现修复弹性。年初以来美护板块受市场情绪、及部分头部品牌线上数据偏弱等影响，出现较大回撤、至26年7月申万美容护理板块YTD跌幅18%，当前头部标的2026E估值基本已经回落至15-25x，板块Q2机构持仓低于0.1%，估值及持仓均处于低位。该机构认为美护板块因产品创新较多，且国货整体处于崛起趋势，仍有较多自下而上高成长机会。当前板块头部公司估值已处于历史低位，随着高端美奢数据企稳改善及市场风格再平衡，该机构认为板块有望展现修复弹性。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987408","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601211","BK0012","BK0201","LU2488822045.USD","LU0348766576.USD","BK0188","LU2242644610.SGD","01318","LU0348767384.USD","02145","KCE","BK1564","BK0184","SG9999004311.SGD","02367","LU0455707207.USD","02657","BK0183","BK1147","BK0276","BK0028","02611","LU0502904849.HKD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655095380","title":"【券商聚焦】华泰证券：美护基本面有支撑，关注再平衡下配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2655095380","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655095380?lang=zh_cn&edition=full","pubTime":"2026-07-31 09:06","pubTimestamp":1785460005,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，美容护理指数 年初以来累计跌19.8%，位列第25/31；PE TTM处2021年以来的16%分位，26Q1基金持仓比例为0.13%位列第30/31。预期/估值/持仓低位，风格再平衡下有望迎来资金面改善。基本面上，除整体消费环境，市场主要担忧：1）市场竞争加剧；2）线上平台增速放缓；3）ROI可能下降及利润率潜在下修风险。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987179","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","02145","LU1064131003.USD","LU1808992512.USD","BK0012","LU0871576103.HKD","LU2488822045.USD","02657","LU0039217434.USD","LU0348766576.USD","LU1781817850.SGD","LU2148510915.USD","01318","LU0164865239.USD","BK1207","LU1934453819.USD","SG9999004311.SGD","BK0188","LU0531971595.HKD","BK0183","601688","LU0502904849.HKD","LU0455707207.USD","LU1580142542.USD","AOK","02367","LU1064130708.USD","LU2242644610.SGD","KCE","LU0348767384.USD","BK0028","BK0276","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190887328","title":"异动解读｜巨子生物盘中上涨5.54%，港股新消费板块集体拉升叠加医美矩阵扩张催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1190887328","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190887328?lang=zh_cn&edition=full","pubTime":"2026-07-29 10:07","pubTimestamp":1785290876,"startTime":"0","endTime":"0","summary":"7月29日，巨子生物盘中上涨5.54%，报30.5港元，成交额6239.09万港元。消息面上，港股新消费概念股盘中集体拉升，板块联动效应明显。公司层面，巨子生物医美产品矩阵近期持续扩张：旗下753胶原针已于6月正式上市，系国内首个重组Ⅰ型胶原蛋白面部注射剂；同月，公司自研交联重组Ⅲ型全长序列胶原蛋白填充剂获NMPA批准，为全球首款用于改善颈纹的同类产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"巨子生物盘中上涨5.54%，港股新消费板块集体拉升叠加医美矩阵扩张催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114853547","title":"港股新消费概念股盘中拉升，布鲁可涨超12%，沪上阿姨涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114853547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114853547?lang=zh_cn&edition=full","pubTime":"2026-07-29 10:05","pubTimestamp":1785290752,"startTime":"0","endTime":"0","summary":"7月29日，港股新消费概念股盘中拉升，$布鲁可(00325)$涨超12%，$沪上阿姨(02589)$涨超7%，$蜜雪集团(02097)$涨近6%，$卫龙美味(09985)$涨超5%，$锅圈(02517)$、$巨子生物(02367)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","VXUS","BK1237","LU0211977185.USD","LU2488822045.USD","BK1207","02517","02367","BK4585","09985","BK1233","02097","02589","BK4588","BK1213","00325","BK1587","BK1132","SG9999004311.SGD","BK1616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197256636","title":"异动解读｜巨子生物盘中下跌5.27%，报27.96港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197256636","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197256636?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:40","pubTimestamp":1784256058,"startTime":"0","endTime":"0","summary":"7月17日，巨子生物盘中下跌5.27%，报27.96港元，成交额5563.98万港元。巨子生物所在的个人用品行业中，板块整体表现偏弱，个股中，毛戈平跌5.06%，上美股份跌4.23%，不同集团跌3.87%，乐舒适跌1.87%，恒安国际涨1.5%。巨子生物控股有限公司是一家主要从事基于生物活性成分的美丽与健康产品的研发、制造及销售业务的投资控股公司。该公司的主要产品包括功效性护肤品、医用敷料等专业皮肤护理产品，以及保健食品及其他产品。该公司主要在国内市场开展业务。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113021524","title":"异动解读｜巨子生物盘中上涨5.13%，医美矩阵密集落地机构看好基本面拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=1113021524","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113021524?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:21","pubTimestamp":1784172107,"startTime":"0","endTime":"0","summary":"7月16日，巨子生物盘中上涨5.13%，报29.9港元，成交额1.25亿港元。消息面上，公司医美产品矩阵近期密集落地，延续前一交易日涨势。6月以来，巨子生物旗下753胶原针正式上市，为国内首个重组Ⅰ型胶原蛋白面部注射剂；同月公司自研交联重组Ⅲ型全长序列胶原蛋白填充剂获NMPA批准，为全球首款用于改善颈纹的同类产品。华创证券研报指出，公司医美矩阵已逐步成型，化妆品舆论风险逐步出清拐点初现。中金、东方证券等多家机构维持正面评级，目标价区间40-43港元，看好公司基本面改善趋势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651581114","title":"港股异动 | 美妆板块涨幅居前 618美妆大盘双位数增长 机构预计美妆行业二季度延续低速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2651581114","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651581114?lang=zh_cn&edition=full","pubTime":"2026-07-15 15:49","pubTimestamp":1784101798,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01318","02657","02145","LU0348767384.USD","LU2488822045.USD","SG9999004311.SGD","02367","LU0455707207.USD","LU2242644610.SGD","LU0502904849.HKD","LU0348766576.USD","BK1207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171158691","title":"异动解读｜巨子生物盘中上涨5.28%，医美矩阵加速成型机构看好拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=1171158691","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171158691?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:53","pubTimestamp":1784084012,"startTime":"0","endTime":"0","summary":"7月15日，巨子生物盘中上涨5.28%，报28.32港元，成交额7072.03万港元。消息面上，巨子生物医美产品矩阵近期密集落地。华创证券研报指出，公司医美矩阵已逐步成型，化妆品舆论风险逐步出清拐点初现。中金、东方证券等多家机构维持正面评级，目标价区间40-43港元，看好公司基本面改善趋势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651289171","title":"【券商聚焦】中信证券：预计美妆行业在次季延续低速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2651289171","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651289171?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:55","pubTimestamp":1783990545,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，22026Q2，预计美妆行业在需求疲弱、流量成本走高、内容运营压力加大的背景下延续低速增长；结构性进一步分化，国际高端品牌销售反弹，本土大众、中端定位品牌承压；毛戈平、林清轩延续高增长，巨子生物、贝泰妮、敷尔佳销售底部回升。2026Q2，医美板块上游产品供给增加，竞争延续较高强度，四环医药受益于自主产品上市继续提升市场份额。估值已充分反映当前的经营压力且已严重低估，静候基本面改善和估值回升。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985765","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1511","LU1328615791.USD","02373","BK1583","BK1207","LU1655091616.SGD","06030","02367","LU1580142542.USD","BK1147","BK1515","BK0188","01696","LU2495084118.USD","LU2148510915.USD","LU2289578879.USD","BK1521","BK1600","BK0028","BK0183","BK1564","KCE","LU1720050803.USD","LU2488822045.USD","LU1255011170.USD","SG9999004311.SGD","LU1997245094.SGD","02196","06699","LU0405327148.USD","LU1064130708.USD","BK1215","02138","BK0012","LU1064131003.USD","01530","00460","LU1997244956.HKD","BK1587","LU1794554557.SGD","BK1585","LU0405327494.USD","HK0000165453.HKD","BK0196","600030","BK1100","BK1161","LU1997245177.USD","BK0276","BK1516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650907973","title":"港股异动 | 巨子生物(02367)盘中涨超6% 巨子生物医美矩阵扩张 机构指舆论风险逐步出清","url":"https://stock-news.laohu8.com/highlight/detail?id=2650907973","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650907973?lang=zh_cn&edition=full","pubTime":"2026-07-10 14:56","pubTimestamp":1783666564,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物盘中涨超6%，截至发稿，涨4.13%，报26.22港元，成交额1.6亿港元。消息面上，巨子生物医美矩阵近期扩张。6月，巨子生物旗下753胶原针正式上市，为国内首个重组Ⅰ型胶原蛋白面部注射剂，差异化切入以Ⅲ型胶原为主流的注射市场。同月，公司自研交联重组Ⅲ型全长序列胶原蛋白填充剂获NMPA批准，为全球首款用于改善颈纹的同类产品。华创证券发布研报称，巨子生物医美矩阵已逐步成型，化妆品舆论风险逐步出清拐点初现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","02367","BK4585","LU2488822045.USD","BK1207","BK4588","SG9999004311.SGD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115556291","title":"异动解读｜巨子生物盘中上涨5.08%，医美双证落地叠加618表现亮眼催化反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1115556291","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115556291?lang=zh_cn&edition=full","pubTime":"2026-07-10 10:32","pubTimestamp":1783650729,"startTime":"0","endTime":"0","summary":"7月10日，巨子生物盘中上涨5.08%，报26.46港元，成交额5467.11万港元。消息面上，近期多家券商发布医美化妆品6月月报，重点提及巨子生物医美矩阵加速扩张。公司由此成为全球首家同时持有重组Ⅰ型和Ⅲ型胶原医美植入剂的企业。此外，618大促期间可复美抖音渠道GMV同比增长超40%，品牌基本盘企稳回升。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103859896","title":"巨子生物6月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1103859896","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103859896?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:57","pubTimestamp":1783069041,"startTime":"0","endTime":"0","summary":"巨子生物控股有限公司于2026年7月3日发布了截至2026年6月30日的证券变动月报表。公告显示，截至本月底，公司法定/注册股本总额维持在5,000,000,000股，面值为每股0.00001美元，法定/注册股本总金额仍为50,000美元，较上月底无变化。在已发行股份及库存股方面，截至6月30日，巨子生物的普通股已发行股份数目为1,061,704,000股，库存股份数目为0股，均与上个月保持一致。公司当月无新增发行、回购或注销股份的情况，亦无库藏股变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647325652","title":"618大促美妆类目取得10%+GMV增速 美妆板块强势 上美股份(02145)涨11.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647325652","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647325652?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:13","pubTimestamp":1782713610,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美妆板块强势，上美股份 涨11.01%，毛戈平涨7.61%，巨子生物涨5.12%。消息面上，东方证券发布研报称，今年618各大平台摒弃冗长的定金机制，全面转向首发即现货的单品直接让利。中信证券表示，本次618大促电商大盘增速降至中单位数、美妆类目取得10%+GMV增速。同时品牌投流向主流平台和核心品类集中，或将加剧流量竞争和投流成本。维持美妆行业“强于大市”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984749","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01318","LU0455707207.USD","BK1207","LU2488822045.USD","02145","LU0502904849.HKD","SG9999004311.SGD","LU0348767384.USD","LU2242644610.SGD","LU0348766576.USD","02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176282011","title":"异动解读｜巨子生物盘中上涨6.43%，618战报超预期叠加个人用品板块集体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1176282011","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176282011?lang=zh_cn&edition=full","pubTime":"2026-06-29 13:02","pubTimestamp":1782709335,"startTime":"0","endTime":"0","summary":"6月29日，巨子生物盘中上涨6.43%，报27.46港元，成交额8313.1万港元。个人用品板块集体走强，上美股份涨14.07%，毛戈平涨9.19%。消息面上，公司近日公布618大促战报，可复美线上全渠道GMV同比增长超25%，可丽金全周期GMV同比增长超30%，可复美成功扭转去年同期下滑趋势。多家券商维持买入或跑赢行业评级，看好公司基本面改善趋势及医美业务商业化进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647879344","title":"【券商聚焦】中信证券：美妆大盘增长降速 仍维持行业“强于大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647879344","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647879344?lang=zh_cn&edition=full","pubTime":"2026-06-29 09:14","pubTimestamp":1782695653,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券表示，本次618大促电商大盘增速降至中单位数、美妆类目取得10%+GMV增速。当前主流平台均加强扶优战略，淘天品牌集中度提升，头部品牌稳健增长；抖音获国际品牌加码投入，国货份额下降、品牌表现分化。同时品牌投流向主流平台和核心品类集中，或将加剧流量竞争和投流成本。维持美妆行业“强于大市”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984659","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02145","LU0455707207.USD","LU2488822045.USD","LU0502904849.HKD","BK1207","02367","LU2242644610.SGD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124468057","title":"异动解读｜巨子生物盘中下跌5.18%，消费板块估值承压叠加前日涨幅回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1124468057","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124468057?lang=zh_cn&edition=full","pubTime":"2026-06-25 10:13","pubTimestamp":1782353639,"startTime":"0","endTime":"0","summary":"6月25日，巨子生物盘中下跌5.18%，报24.9港元，成交额3268.34万港元。个人用品行业整体走弱，板块内不同集团跌8.32%、毛戈平跌3.94%、上美股份跌2.62%。消息面上，此前中金发布研报指出港股消费板块整体估值中枢承压，下调巨子生物目标价18%至40港元。该股昨日因交联重组胶原蛋白植入剂获批消息刺激大涨5.45%，今日出现获利回吐压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":0.098},{"period":"3month","weight":0.028},{"period":"6month","weight":-0.0881},{"period":"1year","weight":-0.4825},{"period":"ytd","weight":-0.0826}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0507},{"period":"3month","weight":-0.036},{"period":"6month","weight":-0.0424},{"period":"1year","weight":0.0188},{"period":"ytd","weight":-0.0074}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家主要从事基于生物活性成分的美丽与健康产品的研发、制造及销售业务的投资控股公司。该公司的主要产品包括功效性护肤品、医用敷料等专业皮肤护理产品，以及保健食品及其他产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.063748},{"month":2,"riseRate":0.75,"avgChangeRate":0.082293},{"month":3,"riseRate":0.75,"avgChangeRate":0.04973},{"month":4,"riseRate":0.75,"avgChangeRate":0.023756},{"month":5,"riseRate":0.25,"avgChangeRate":-0.038833},{"month":6,"riseRate":0.25,"avgChangeRate":-0.059254},{"month":7,"riseRate":0.5,"avgChangeRate":0.005281},{"month":8,"riseRate":0.5,"avgChangeRate":0.000568},{"month":9,"riseRate":0.666667,"avgChangeRate":0.061774},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.12614},{"month":11,"riseRate":0.333333,"avgChangeRate":0.019826},{"month":12,"riseRate":0.25,"avgChangeRate":0.047111}],"exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}